Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Clinical Microbiology|August 22, 2014
Characterization of multiple cytomegalovirus drug resistance mutations detected in a hematopoietic stem cell transplant recipient by recombinant phenotypingEmilien Drouot, Jocelyne Piret, Marc H Lebel, et al.Transfusion|July 5, 2019
Reevaluating immunization delays after red blood cell transfusionAlexandra Zabeida, Marc H Lebel, Christian Renaud, et al.Journal of the Pediatric Infectious Diseases Society|June 13, 2020
Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec StudyJesse Papenburg, Isabelle Defoy, Edith Massé, et al.Vaccine|May 4, 2004
Hospitalisations for gastroenteritis: the role of rotavirusPaul Rivest, Mélanie Proulx, Guy Lonergan, et al.Paediatrics & Child Health|March 2, 2011
The rise of the rats: A growing paediatric issueKarine Khatchadourian, Philippe Ovetchkine, Philippe Minodier, et al.Journal of Paediatrics and Child Health|September 7, 2007
Prevalence of positive tuberculin skin tests in foreign-born childrenKristine Fortin, Ana Carceller, Monique Robert, et al.Journal of Paediatrics and Child Health|November 18, 2008
Antibiotic prophylaxis for childhood urinary tract infection: a national surveyIsabelle Chevalier, Geneviève Benoît, Marie Gauthier, et al.Paediatrics & Child Health|November 26, 2008
Palivizumab use among children with congenital heart disease in Quebec: Impact of Canadian guidelines on clinical practiceMarc Bellavance, Charles V Rohlicek, Jean-Luc Bigras, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2003
A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in CanadaMarc H Lebel, James D Kellner, E Lee Ford-Jones, et al.The Pediatric Infectious Disease Journal|July 18, 2012
Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicityJoanne M Langley, Dennis Reich, Naresh Aggarwal, et al.Pageof 2